Anika Therapeutics Inc (ANIK)

R&D to Revenue

22.51%

Quarterly · Period ending:

ANIK logo

ANIK R&D to Revenue

Latest reported22.51%
ANIK Quarterly R&D/Revenue (0.00% → 22.51%)
High-resolution chart · PNG

ANIK r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
31.5627%
61.8681%
7.3477%
18.9087%
24.0723%
48.2844%
46.6667%
34.2857%
23.6842%
21.875%
17.6471%
15.625%
8.6957%
17.8571%
8.3333%
37.5%
20%
15.7895%
54.5455%
38.4615%
33.3333%
40%
33.3333%
44.4444%
33.3333%
42.8571%
44.4444%
36.3636%
40%
28.5714%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.